A citation-based method for searching scientific literature

Delyan P Ivanov, Beth Coyle, David A Walker, Anna M Grabowska. J Biotechnol 2016
Times Cited: 115







List of co-cited articles
562 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Florence M G Cavalli, Marc Remke, Ladislav Rampasek, John Peacock, David J H Shih, Betty Luu, Livia Garzia, Jonathon Torchia, Carolina Nor, A Sorana Morrissy,[...]. Cancer Cell 2017
558
47

Molecular subgroups of medulloblastoma: the current consensus.
Michael D Taylor, Paul A Northcott, Andrey Korshunov, Marc Remke, Yoon-Jae Cho, Steven C Clifford, Charles G Eberhart, D Williams Parsons, Stefan Rutkowski, Amar Gajjar,[...]. Acta Neuropathol 2012
41

The whole-genome landscape of medulloblastoma subtypes.
Paul A Northcott, Ivo Buchhalter, A Sorana Morrissy, Volker Hovestadt, Joachim Weischenfeldt, Tobias Ehrenberger, Susanne Gröbner, Maia Segura-Wang, Thomas Zichner, Vasilisa A Rudneva,[...]. Nature 2017
524
33

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
25

Medulloblastoma.
Paul A Northcott, Giles W Robinson, Christian P Kratz, Donald J Mabbott, Scott L Pomeroy, Steven C Clifford, Stefan Rutkowski, David W Ellison, David Malkin, Michael D Taylor,[...]. Nat Rev Dis Primers 2019
233
23

Medulloblastoma comprises four distinct molecular variants.
Paul A Northcott, Andrey Korshunov, Hendrik Witt, Thomas Hielscher, Charles G Eberhart, Stephen Mack, Eric Bouffet, Steven C Clifford, Cynthia E Hawkins, Pim French,[...]. J Clin Oncol 2011
879
20

Subgroup-specific structural variation across 1,000 medulloblastoma genomes.
Paul A Northcott, David J H Shih, John Peacock, Livia Garzia, A Sorana Morrissy, Thomas Zichner, Adrian M Stütz, Andrey Korshunov, Jüri Reimand, Steven E Schumacher,[...]. Nature 2012
582
20

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.
Marcel Kool, Andrey Korshunov, Marc Remke, David T W Jones, Maria Schlanstein, Paul A Northcott, Yoon-Jae Cho, Jan Koster, Antoinette Schouten-van Meeteren, Dannis van Vuurden,[...]. Acta Neuropathol 2012
638
19

Medulloblastomics: the end of the beginning.
Paul A Northcott, David T W Jones, Marcel Kool, Giles W Robinson, Richard J Gilbertson, Yoon-Jae Cho, Scott L Pomeroy, Andrey Korshunov, Peter Lichter, Michael D Taylor,[...]. Nat Rev Cancer 2012
425
18

Novel mutations target distinct subgroups of medulloblastoma.
Giles Robinson, Matthew Parker, Tanya A Kranenburg, Charles Lu, Xiang Chen, Li Ding, Timothy N Phoenix, Erin Hedlund, Lei Wei, Xiaoyan Zhu,[...]. Nature 2012
589
18

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Edward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, Stephen Crosier, Amanda J Smith, Debbie Hicks, Gholamreza Rafiee, Rebecca M Hill, Alice Iliasova, Thomas Stone,[...]. Lancet Oncol 2017
279
17

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
Marcel Kool, David T W Jones, Natalie Jäger, Paul A Northcott, Trevor J Pugh, Volker Hovestadt, Rosario M Piro, L Adriana Esparza, Shirley L Markant, Marc Remke,[...]. Cancer Cell 2014
480
16

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Vijay Ramaswamy, Marc Remke, Eric Bouffet, Simon Bailey, Steven C Clifford, Francois Doz, Marcel Kool, Christelle Dufour, Gilles Vassal, Till Milde,[...]. Acta Neuropathol 2016
326
14

Dissecting the genomic complexity underlying medulloblastoma.
David T W Jones, Natalie Jäger, Marcel Kool, Thomas Zichner, Barbara Hutter, Marc Sultan, Yoon-Jae Cho, Trevor J Pugh, Volker Hovestadt, Adrian M Stütz,[...]. Nature 2012
604
13

Subtypes of medulloblastoma have distinct developmental origins.
Paul Gibson, Yiai Tong, Giles Robinson, Margaret C Thompson, D Spencer Currle, Christopher Eden, Tanya A Kranenburg, Twala Hogg, Helen Poppleton, Julie Martin,[...]. Nature 2010
544
13

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.
Paul A Northcott, David J H Shih, Marc Remke, Yoon-Jae Cho, Marcel Kool, Cynthia Hawkins, Charles G Eberhart, Adrian Dubuc, Toumy Guettouche, Yoslayma Cardentey,[...]. Acta Neuropathol 2012
258
12

A mouse model of the most aggressive subgroup of human medulloblastoma.
Daisuke Kawauchi, Giles Robinson, Tamar Uziel, Paul Gibson, Jerold Rehg, Cuilan Gao, David Finkelstein, Chunxu Qu, Stanley Pounds, David W Ellison,[...]. Cancer Cell 2012
200
12

An animal model of MYC-driven medulloblastoma.
Yanxin Pei, Colin E Moore, Jun Wang, Alok K Tewari, Alexey Eroshkin, Yoon-Jae Cho, Hendrik Witt, Andrey Korshunov, Tracy-Ann Read, Julia L Sun,[...]. Cancer Cell 2012
205
12

HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment.
Till Milde, Marco Lodrini, Larissa Savelyeva, Andrey Korshunov, Marcel Kool, Lena M Brueckner, André S L M Antunes, Ina Oehme, Arnulf Pekrun, Stefan M Pfister,[...]. J Neurooncol 2012
78
15

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Trevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, Daniel A Pomeranz Krummel, Daniel Auclair, James Bochicchio, Mauricio O Carneiro, Scott L Carter, Kristian Cibulskis, Rachel L Erlich,[...]. Nature 2012
545
12

Altered neural cell fates and medulloblastoma in mouse patched mutants.
L V Goodrich, L Milenković, K M Higgins, M P Scott. Science 1997
11

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, Elke Pfaff, David J H Shih, Dianna C Martin, Pedro Castelo-Branco, Berivan Baskin, Peter N Ray, Eric Bouffet,[...]. J Clin Oncol 2013
284
11

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
Yoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, Sandro Santagata, Azra Ligon, Heidi Greulich, Rameen Berhoukim, Vladimir Amani, Liliana Goumnerova, Charles G Eberhart,[...]. J Clin Oncol 2011
493
11

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.
Giles W Robinson, Brent A Orr, Gang Wu, Sridharan Gururangan, Tong Lin, Ibrahim Qaddoumi, Roger J Packer, Stewart Goldman, Michael D Prados, Annick Desjardins,[...]. J Clin Oncol 2015
263
10

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Marcel Kool, Jan Koster, Jens Bunt, Nancy E Hasselt, Arjan Lakeman, Peter van Sluis, Dirk Troost, Netteke Schouten-van Meeteren, Huib N Caron, Jacqueline Cloos,[...]. PLoS One 2008
512
10

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
10

Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma.
Ulrich Schüller, Vivi M Heine, Junhao Mao, Alvin T Kho, Allison K Dillon, Young-Goo Han, Emmanuelle Huillard, Tao Sun, Azra H Ligon, Ying Qian,[...]. Cancer Cell 2008
446
10

Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells.
Zeng-Jie Yang, Tammy Ellis, Shirley L Markant, Tracy-Ann Read, Jessica D Kessler, Melissa Bourboulas, Ulrich Schüller, Robert Machold, Gord Fishell, David H Rowitch,[...]. Cancer Cell 2008
471
10

Resolving medulloblastoma cellular architecture by single-cell genomics.
Volker Hovestadt, Kyle S Smith, Laure Bihannic, Mariella G Filbin, McKenzie L Shaw, Alicia Baumgartner, John C DeWitt, Andrew Groves, Lisa Mayr, Hannah R Weisman,[...]. Nature 2019
157
10

BET bromodomain inhibition of MYC-amplified medulloblastoma.
Pratiti Bandopadhayay, Guillaume Bergthold, Brian Nguyen, Simone Schubert, Sharareh Gholamin, Yujie Tang, Sara Bolin, Steven E Schumacher, Rhamy Zeid, Sabran Masoud,[...]. Clin Cancer Res 2014
233
9

HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.
Yanxin Pei, Kun-Wei Liu, Jun Wang, Alexandra Garancher, Ran Tao, Lourdes A Esparza, Donna L Maier, Yoko T Udaka, Najiba Murad, Sorana Morrissy,[...]. Cancer Cell 2016
160
9

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Sebastian M Waszak, Paul A Northcott, Ivo Buchhalter, Giles W Robinson, Christian Sutter, Susanne Groebner, Kerstin B Grund, Laurence Brugières, David T W Jones, Kristian W Pajtler,[...]. Lancet Oncol 2018
177
9

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
Vijay Ramaswamy, Marc Remke, Eric Bouffet, Claudia C Faria, Sebastien Perreault, Yoon-Jae Cho, David J Shih, Betty Luu, Adrian M Dubuc, Paul A Northcott,[...]. Lancet Oncol 2013
234
9

Childhood cerebellar tumours mirror conserved fetal transcriptional programs.
Maria C Vladoiu, Ibrahim El-Hamamy, Laura K Donovan, Hamza Farooq, Borja L Holgado, Yogi Sundaravadanam, Vijay Ramaswamy, Liam D Hendrikse, Sachin Kumar, Stephen C Mack,[...]. Nature 2019
170
9

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Amar Gajjar, Murali Chintagumpala, David Ashley, Stewart Kellie, Larry E Kun, Thomas E Merchant, Shaio Woo, Greg Wheeler, Valerie Ahern, Matthew J Krasin,[...]. Lancet Oncol 2006
602
9

Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.
Joanna Triscott, Cathy Lee, Colleen Foster, Branavan Manoranjan, Mary Rose Pambid, Rachel Berns, Abbas Fotovati, Chitra Venugopal, Katrina O'Halloran, Aru Narendran,[...]. Cancer Res 2013
70
11

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
Rebecca M Hill, Sanne Kuijper, Janet C Lindsey, Kevin Petrie, Ed C Schwalbe, Karen Barker, Jessica K R Boult, Daniel Williamson, Zai Ahmad, Albert Hallsworth,[...]. Cancer Cell 2015
129
8

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
David W Ellison, James Dalton, Mehmet Kocak, Sarah Leigh Nicholson, Charles Fraga, Geoff Neale, Anna M Kenney, Dan J Brat, Arie Perry, William H Yong,[...]. Acta Neuropathol 2011
349
8

Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.
Matija Snuderl, Ana Batista, Nathaniel D Kirkpatrick, Carmen Ruiz de Almodovar, Lars Riedemann, Elisa C Walsh, Rachel Anolik, Yuhui Huang, John D Martin, Walid Kamoun,[...]. Cell 2013
169
8

The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.
Beryl A Hatton, Elisabeth H Villavicencio, Karen D Tsuchiya, Joel I Pritchard, Sally Ditzler, Barbara Pullar, Stacey Hansen, Sue E Knoblaugh, Donghoon Lee, Charles G Eberhart,[...]. Cancer Res 2008
126
8

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
Paul A Northcott, Catherine Lee, Thomas Zichner, Adrian M Stütz, Serap Erkek, Daisuke Kawauchi, David J H Shih, Volker Hovestadt, Marc Zapatka, Dominik Sturm,[...]. Nature 2014
377
8

The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival.
Eric M Thompson, Stephen T Keir, Talaignair Venkatraman, Christopher Lascola, Kristen W Yeom, Andrew B Nixon, Yingmiao Liu, Daniel Picard, Marc Remke, Darell D Bigner,[...]. Neuro Oncol 2017
38
21

Medulloblastomics revisited: biological and clinical insights from thousands of patients.
Volker Hovestadt, Olivier Ayrault, Fredrik J Swartling, Giles W Robinson, Stefan M Pfister, Paul A Northcott. Nat Rev Cancer 2020
77
10

Medullospheres from DAOY, UW228 and ONS-76 cells: increased stem cell population and proteomic modifications.
Cristina Zanini, Elisabetta Ercole, Giorgia Mandili, Roberta Salaroli, Alice Poli, Cristiano Renna, Valentina Papa, Giovanna Cenacchi, Marco Forni. PLoS One 2013
33
21

Medulloblastoma-translating discoveries from the bench to the bedside.
Amar J Gajjar, Giles W Robinson. Nat Rev Clin Oncol 2014
118
7

Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.
Robert L Yauch, Gerrit J P Dijkgraaf, Bruno Alicke, Thomas Januario, Christina P Ahn, Thomas Holcomb, Kanan Pujara, Jeremy Stinson, Christopher A Callahan, Tracy Tang,[...]. Science 2009
649
7

Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med.
H S Friedman, P C Burger, S H Bigner, J Q Trojanowski, C J Wikstrand, E C Halperin, D D Bigner. J Neuropathol Exp Neurol 1985
184
7

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Margaret C Thompson, Christine Fuller, Twala L Hogg, James Dalton, David Finkelstein, Ching C Lau, Murali Chintagumpala, Adekunle Adesina, David M Ashley, Stewart J Kellie,[...]. J Clin Oncol 2006
493
7

Medulloblastoma: From Myth to Molecular.
Vijay Ramaswamy, Michael D Taylor. J Clin Oncol 2017
95
7

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
Charles M Rudin, Christine L Hann, John Laterra, Robert L Yauch, Christopher A Callahan, Ling Fu, Thomas Holcomb, Jeremy Stinson, Stephen E Gould, Barbara Coleman,[...]. N Engl J Med 2009
775
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.